Clinical trials
Withdrawn Schizophrenia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| NYU Langone Health | 3 |
| VA Office of Research and Development | 3 |
| Massachusetts General Hospital | 2 |
| University of Maryland, Baltimore | 2 |
| University of Minnesota | 2 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
| Duke University | 1 |
| Indiana University | 1 |
| Lisa Dixon | 1 |
| Mclean Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 31 |
| Psychotic Disorders | 11 |
| Bipolar Disorder | 4 |
| Major Depressive Disorder | 2 |
| Mental Disorders | 2 |
| Cognitive Dysfunction | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Hallucinations | 1 |
| Inflammation | 1 |
| Nervous System Diseases | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.